Taught by Dr. Crowthers, this course centers around scientific research, engineering design, and clear technical communication. In this first part of the class, we conduct independent research projects involving literature review, experimental design, data analysis, and presentation, culminating in a school-wide science fair with opportunities for advancement to higher-level competitions.
This project investigates the potential of enhancing the insulin signaling pathway in Drosophila melanogaster to mitigate neurodegenerative effects associated with Alzheimer's disease (AD) and traumatic brain injury (TBI). By manipulating the insulin signaling pathway, we aim to determine its impact on locomotive ability, learning, and memory in an AD model. Additionally, we have developed a novel HIT device designed to produce consistent and reproducible head impacts for TBI research in Drosophila. We have found that increasing the strength of the insulin signaling pathway leads to neuroprotection in flies which we can see through improved locomotion and rescue of learning deficits.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid-β (Aβ) and tau proteins, leading to cognitive and motor decline. Though more than 6 million Americans have AD, there is no cure or sufficiently effective treatment, and many underlying disease mechanisms remain unresolved. One area of ongoing debate is the role of the insulin signaling pathway (ISP) in neurodegeneration. While Huang et al. in 2019 found that hampering the ISP can lead to reduced Aβ toxicity and lowered levels of neurodegeneration, other studies such as Mullins et al. in 2017 have found that insulin resistance is a major risk factor in a cascade of brain damage that leads to AD. To address this discrepancy, this study proposes using Drosophila melanogaster to examine how altering insulin signaling affects neurodegenerative outcomes in an AD-like model induced by traumatic brain injury (TBI). Flies with enhanced or reduced insulin signaling were subject to controlled mechanical injury using a novel high-impact-trauma (HIT) device, and neurodegeneration was quantified using negative geotaxis and olfactory T-maze assays. The flies with enhanced insulin signaling showed a 18.2% lower decline in climbing ability (p<0.001) and a 36% lower impairment in learning performance (p<0.05) compared to the controls. These results indicate that elevated insulin signaling protects against TBI-induced neurodegeneration. This suggests the ISP plays a key role in protecting against neurodegeneration. Therapeutic strategies preventing insulin pathway suppression may offer promising avenues for mitigating neurodegeneration in AD and brain injury-related conditions.
How does manipulating the insulin signaling pathway in Drosophila melanogaster influence markers associated with neurodegenerative effects in an AD model?
Enhancing the insulin signaling pathway in Drosophila will reduce neurodegeneration through markers such as locomotive ability and memory in an AD model.
Alzheimer's Disease (AD) is a devastating neurodegenerative disorder affecting over 6 million Americans and ranking as the seventh leading cause of death in the United States. The disease progressively destroys memory, thinking skills, and behavioral regulation through the accumulation of toxic proteins such as amyloid-beta (Aβ) and tau in the brain. While AD predominantly affects elderly individuals—likely due to age-related inflammation, blood vessel damage, and brain atrophy—emerging research reveals a complex relationship between metabolic dysfunction and neurodegeneration. This connection has led many in the medical community to describe Alzheimer's as "Type 3 Diabetes," reflecting the critical role of insulin resistance in the disease's progression. When insulin resistance develops, insulin degrading enzymes (IDEs) become overwhelmed breaking down excess insulin rather than clearing Aβ peptides, leading to toxic protein accumulation and subsequent neurodegeneration.
The role of insulin signaling in the brain presents a fascinating paradox. While insulin resistance clearly contributes to Alzheimer's pathology, research in Drosophila melanogaster reveals that genetically reducing insulin signaling pathway (ISP) activity can actually protect against Aβ toxicity. Studies have shown that knocking down chico—a gene encoding the fruit fly equivalent of Insulin Receptor Substrate-1 that bridges the insulin receptor to downstream signaling components—significantly improves locomotor ability and reduces brain vacuolization in flies expressing toxic Aβ protein. Similar neuroprotective effects occur when other key ISP components like dInR or PI3K are knocked out. This protection appears to work by activating stress-response pathways and increasing autophagy, creating a cellular environment more resistant to protein toxicity. Conversely, chronically elevating insulin signaling through InR overexpression reduces autophagy, promotes excessive cellular growth, lowers stress resistance, and in some cases worsens neurodegenerative symptoms, suggesting that the optimal level of insulin signaling for brain health may fall within a critical range.
Multiple pathological triggers can initiate Alzheimer's-like neurodegeneration, making it essential to test potential interventions across different disease models. High-sugar diets cause metabolic dysregulation leading to Type 2 diabetes, which represents one of the biggest risk factors for AD alongside aging itself. Traumatic brain injury (TBI) presents another powerful trigger, as individuals sustaining moderate to severe TBI show significantly elevated risk of dementia later in life. Following injury, the brain exhibits chronic inflammation, tau hyperphosphorylation, oxidative stress, and impaired clearance of toxic proteins—mechanisms that closely mirror the pathological cascade of AD. These overlapping mechanisms make TBI particularly valuable for creating Alzheimer's-relevant models, as it can initiate or exacerbate AD-like neurodegeneration in genetically or metabolically vulnerable individuals through ethically accessible experimental procedures.
Drosophila melanogaster serves as an ideal organism for investigating these complex relationships between insulin signaling and neurodegeneration. Fruit flies offer significant advantages over alternative model organisms: they lack the ethical concerns associated with vertebrate research, can be maintained cheaply in large quantities, and possess highly conserved signaling pathways and cellular processes that directly translate to human biology. Neurodegeneration in flies manifests through measurable declines in locomotion, memory, and behavioral regulation—all mediated by neural circuits remarkably similar to those in humans. Locomotor deficits assessed through climbing assays reflect motor neuron dysfunction, neuromuscular weakness, and mitochondrial decline. Memory and learning capacity can be quantified using olfactory T-maze assays, where flies choose between arms containing isoamyl acetate (an initially aversive odorant) versus distilled water; naïve flies avoid the odorant while conditioned flies learn it's harmless, with the shift in distribution revealing learning capacity. Aggressive behavior, measured through controlled male-male interactions, provides insight into higher-order behavioral dysfunction caused by neural impairment. Despite extensive research demonstrating that ISP modulation affects Aβ toxicity, the differential effects of reducing versus enhancing insulin signaling across multiple neurodegenerative markers and various AD-relevant stressors remain incompletely understood, creating an opportunity to identify potential therapeutic strategies for combating neurodegeneration.
Over a 26-week period from mid-August 2025 to mid-February 2026, I independently designed and conducted all experimental procedures for this investigation into traumatic brain injury and insulin signaling in Drosophila melanogaster. Active experimentation began in mid-November 2025, during which I was responsible for all aspects of the research including behavioral assays, TBI induction procedures, data collection, and statistical analyses. Dr. C provided guidance on Drosophila husbandry techniques, including preparation of culture media and protocols for separating male and female flies for experimental crosses, but all experimental work and analysis was performed independently.
The research utilized wild-type Drosophila melanogaster (Oregon-R strain) and transgenic flies carrying UAS-InR (Bloomington Drosophila Stock Center stock #8263), which contains an overexpression construct for the Drosophila insulin receptor under UAS (upstream activating sequence) control. Flies were maintained in standard polypropylene vials on cornmeal-agar medium prepared according to Bloomington Stock Center protocols. To induce traumatic brain injury, I constructed a custom high-impact trauma (HIT) device modeled after the design described by Katzenberger et al. (2013), consisting of a spring-loaded mechanism, shock-absorbing foam pad, and standardized vial holders. The TBI protocol involved three consecutive strikes at 5.0 m/s and 2.5 N net force with 10-second recovery intervals between strikes, which preliminary trials validated as producing consistent behavioral deficits while maintaining over 90% survival rates.
Behavioral assessments were conducted 24 hours post-TBI using two complementary assays. Locomotor function was evaluated through a negative geotaxis climbing assay, where groups of 30 flies were placed in vertical columns with graduated markings and tapped to the bottom. The proportion of flies climbing above a 10 cm mark within 10 seconds was recorded across four independent trials for each experimental group, providing a measure of motor neuron dysfunction and central nervous system damage. Learning and memory were assessed using an olfactory T-maze apparatus constructed from clear acrylic tubing in a T-configuration. Flies were first tested for baseline olfactory preference to isoamyl acetate (diluted 1:100 in mineral oil), then conditioned through 30-minute exposure to the odorant, and finally retested. The learning index was calculated as the difference between post-conditioning and naïve preference indices across three independent trials of 30 flies each, quantifying each group's capacity for associative learning.
Statistical analyses employed multiple approaches to ensure robust interpretation of results. Independent t-tests were used to determine whether TBI significantly impaired motor function and olfactory learning in both wildtype and insulin receptor-enhanced flies, as well as to directly compare the neuroprotective effects between genotypes. One-way ANOVA tested for overall differences across all four experimental groups (wildtype control, wildtype TBI, InR control, and InR TBI). Chi-square tests evaluated whether flies could learn to associate olfactory cues with reward by comparing naïve versus trained choice distributions, and whether TBI impaired this learning ability. All statistical tests used a significance threshold of α = 0.05, and flies were anesthetized using CO₂ from a compressed gas cylinder at 5 psi for sorting and transfer procedures throughout the experiment.
From the results, it can be found that TBI causes severe deficits in motor function and learning in WT flies (all p < 0.05). Moreover, increased INR significantly reduces motor deficits (p = 0.0015). While WT TBI flies completely lose the ability to learn (p = 0.595), InR TBI flies retain learning ability (p = 0.011).
>This project resolves conflicting evidence about the role of insulin signaling in neurodegeneration. It has shown that enhanced insulin signaling can protect against neurodegenerative effects following brain trauma, highlighting metabolic signaling pathways as potential therapeutic targets for AD and TBI. Finally, this project proposes a novel HIT device that produces easy, fast, and reproducible strikes for TBI research using Drosophila.